Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
NIOX

NIOX Group Plc

NIOXLSEUnited KingdomHealthcareMedical DevicesFTSE AIM 100

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual…more

P/E32.83xP/B4.05xROIC13.9%Dividend yield2.4%
£276.30M
Market Cap
EV: £255.24M
MOM2
QUAL8
VAL4
RSK3
NIOX
£276.30M
Market Cap · EV £255.24M

NIOX Group Plc

MOM2
QUAL8
VAL4
RSK3

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual…more

Latest RNS from NIOX Group Plc

Analyst consensus: Buy

As of 6 Oct 2026, 6 analysts rate NIOX Group Plc a Buy, with 100% buy ratings and a mean price target of 82p (range 77p–86p), +22% vs the current price.

Strong buy: 0Buy: 6Hold: 0Sell: 0Strong sell: 0

Full analyst history →

Valuation vs peers

Peer-relative fair value estimate: 43p against a current price of 67p (-36%), based on EV/EBITDA.

More Healthcare companies